Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grzelka

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Polish Archives of Internal Medicine|January 5, 2023
Indirect insulin resistance markers are associated with nonalcoholic fatty liver disease in type 1 diabetesAgata Grzelka-Woźniak, Aleksandra Uruska, Elektra Szymańska-Garbacz, et al.
Journal of Diabetes and Its Complications|July 31, 2024
An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetesAndrzej S Januszewski, Agata Grzelka-Wozniak, Justyna Flotynska, et al.
Endocrine Connections|June 4, 2025
Clinical remission in newly diagnosed type 1 diabetes mellitus and HDL function on cholesterol efflux capacity: prospective InLipoDiab1 studyAleksandra Uruska, Maja Mietkiewska-Dolecka, Agata Grzelka-Wozniak, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 21, 2020
Pseudoneutropenia as a factor-limiting access to chemotherapy for cancer patients: the effect of a simple mealAnna Waszczuk-Gajda, Leszek Kraj, Krzysztof Woźniak, et al.
Archives of Medical Science : AMS|May 20, 2022
Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 studyAleksandra Cieluch, Aleksandra Uruska, Marcin Nowicki, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Suppression of serum lipid transfer proteins involved in high-density lipoprotein cholesterol metabolism by intensive insulin therapy in the first year of type 1 diabetes mellitus: Prospective InLipoDiab1 studyAleksandra Cieluch, Aleksandra Uruska, Marcin Nowicki, et al.
Diabetes & Vascular Disease Research|May 31, 2019
An increased skin microvessel density is associated with neurovascular complications in type 1 diabetes mellitusAnna Adamska, Stanislaw Pilacinski, Dorota Zozulinska-Ziolkiewicz, et al.
Microvascular Research|January 14, 2015
Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective StudyAleksandra Araszkiewicz, Dariusz Naskret, Dorota Zozulinska-Ziolkiewicz, et al.
Microvascular Research|October 13, 2018
Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetesAnna Adamska, Aleksandra Araszkiewicz, Stanislaw Pilacinski, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|April 17, 2024
Better Cardiorespiratory Fitness Defined as VO<sub>2</sub>max Increases the Chance of Partial Clinical Remission and Prolongs Remission Duration in People with Newly Diagnosed Type 1 DiabetesJustyna Flotyńska, Dariusz Naskręt, Paweł Niedźwiecki, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Polish Archives of Internal Medicine|January 5, 2023
Indirect insulin resistance markers are associated with nonalcoholic fatty liver disease in type 1 diabetesAgata Grzelka-Woźniak, Aleksandra Uruska, Elektra Szymańska-Garbacz, et al.
Journal of Diabetes and Its Complications|July 31, 2024
An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetesAndrzej S Januszewski, Agata Grzelka-Wozniak, Justyna Flotynska, et al.
Endocrine Connections|June 4, 2025
Clinical remission in newly diagnosed type 1 diabetes mellitus and HDL function on cholesterol efflux capacity: prospective InLipoDiab1 studyAleksandra Uruska, Maja Mietkiewska-Dolecka, Agata Grzelka-Wozniak, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 21, 2020
Pseudoneutropenia as a factor-limiting access to chemotherapy for cancer patients: the effect of a simple mealAnna Waszczuk-Gajda, Leszek Kraj, Krzysztof Woźniak, et al.
Archives of Medical Science : AMS|May 20, 2022
Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 studyAleksandra Cieluch, Aleksandra Uruska, Marcin Nowicki, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Suppression of serum lipid transfer proteins involved in high-density lipoprotein cholesterol metabolism by intensive insulin therapy in the first year of type 1 diabetes mellitus: Prospective InLipoDiab1 studyAleksandra Cieluch, Aleksandra Uruska, Marcin Nowicki, et al.
Diabetes & Vascular Disease Research|May 31, 2019
An increased skin microvessel density is associated with neurovascular complications in type 1 diabetes mellitusAnna Adamska, Stanislaw Pilacinski, Dorota Zozulinska-Ziolkiewicz, et al.
Microvascular Research|January 14, 2015
Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective StudyAleksandra Araszkiewicz, Dariusz Naskret, Dorota Zozulinska-Ziolkiewicz, et al.
Microvascular Research|October 13, 2018
Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetesAnna Adamska, Aleksandra Araszkiewicz, Stanislaw Pilacinski, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|April 17, 2024
Better Cardiorespiratory Fitness Defined as VO<sub>2</sub>max Increases the Chance of Partial Clinical Remission and Prolongs Remission Duration in People with Newly Diagnosed Type 1 DiabetesJustyna Flotyńska, Dariusz Naskręt, Paweł Niedźwiecki, et al.
Pageof 6